Vitanorm (Capsules) Instructions for Use
Marketing Authorization Holder
Nizhpharm JSC (Russia)
ATC Codes
A05AX (Other drugs for the treatment of diseases of the biliary tract)
G04CX (Other drugs for the treatment of benign prostatic hyperplasia)
Active Substance
Pumpkin seed (BP British Pharmacopoeia)
Dosage Form
| Vitanorm | Capsules 200 mg: 50 or 84 pcs. |
Dosage Form, Packaging, and Composition
| Capsules | 1 caps. |
| Pumpkin seed oil | 200 mg |
15 pcs. – dark glass jars (1) – cardboard packs.
Clinical-Pharmacological Group
Herbal preparation with hepatoprotective, choleretic, antioxidant, and anti-inflammatory action
Pharmacotherapeutic Group
Hepatoprotective agent of plant origin
Pharmacological Action
Herbal remedy. Contains biologically active substances obtained from pumpkin (carotenoids, tocopherols, phospholipids, sterols, phosphatides, flavonoids, vitamins B1, B2, C, P, PP, F, saturated, unsaturated and polyunsaturated fatty acids – palmitic, stearic, oleic, linoleic, linolenic, arachidonic). It has antiulcer, hepatoprotective and choleretic effects. Reduces the proliferation of prostate cells. It has an anti-inflammatory effect.
Pumpkin seeds have anthelmintic activity against tapeworms (including beef tapeworm, pork tapeworm, dwarf tapeworm, broad tapeworm). It is believed that the component with anthelmintic action is contained mainly in the thin gray-green shell inside the pumpkin seed.
Indications
For oral administration: hepatitis, fatty liver, cholecystocholangitis, biliary dyskinesia, gastritis, heartburn, gastric and duodenal ulcer, colitis, enterocolitis, hemorrhoids, atherosclerosis, prostatitis, benign prostatic hyperplasia, cervical erosion. Deworming and prevention of parasite carriage of various tapeworms.
For external and local use: herpes, dermatitis, diathesis, psoriasis, eczema, burns and burn disease, periodontitis.
ICD codes
| ICD-10 code | Indication |
| B00 | Herpesviral [herpes simplex] infections |
| B83.9 | Helminthiases, unspecified |
| I70 | Atherosclerosis |
| K05 | Gingivitis and periodontal diseases |
| K25 | Gastric ulcer |
| K26 | Duodenal ulcer |
| K29 | Gastritis and duodenitis |
| K52.9 | Noninfective gastroenteritis and colitis, unspecified |
| K64 | Hemorrhoids and perianal venous thrombosis |
| K73 | Chronic hepatitis, not elsewhere classified |
| K76.0 | Fatty (change of) liver, not elsewhere classified |
| K81.0 | Acute cholecystitis |
| K81.1 | Chronic cholecystitis |
| K82.8 | Other specified diseases of gallbladder and cystic duct (including dyskinesia) |
| K83.0 | Cholangitis |
| L20.8 | Other atopic dermatitis (neurodermatitis, eczema) |
| L30.0 | Nummular eczema |
| L30.9 | Dermatitis, unspecified |
| L40 | Psoriasis |
| N40 | Hyperplasia of prostate |
| N41 | Inflammatory diseases of prostate |
| N86 | Erosion and ectropion of cervix |
| R12 | Heartburn |
| T30 | Burns and corrosions of unspecified body region |
| ICD-11 code | Indication |
| 1F00.Z | Infections due to herpes simplex virus, unspecified |
| 1F9Z | Helminthiases, unspecified |
| 9A06.70 | Atopic eczema of the eyelids |
| BD40.Z | Atherosclerosis of peripheral arteries, unspecified |
| DA0B.Z | Gingival diseases, unspecified |
| DA0C.Z | Periodontal diseases, unspecified |
| DA0Z | Diseases or disorders of the orofacial complex, unspecified |
| DA42.Z | Gastritis, unspecified |
| DA51.Z | Duodenitis, unspecified |
| DA60.Z | Gastric ulcer, unspecified |
| DA63.Z | Duodenal ulcer, unspecified |
| DA7Z | Diseases of stomach or duodenum, unspecified |
| DA90.0 | Syndromic diarrhea |
| DB6Z | Hemorrhoids or perianal venous diseases, unspecified |
| DB92.0 | Non-alcoholic fatty liver disease without steatohepatitis |
| DB92.Y | Other specified non-alcoholic fatty liver disease |
| DB92.Z | Non-alcoholic fatty liver disease, unspecified |
| DB97.2 | Chronic hepatitis, not elsewhere classified |
| DC12.0Z | Acute cholecystitis, unspecified |
| DC12.1 | Chronic cholecystitis |
| DC13 | Cholangitis |
| DC1Z | Diseases of gallbladder and biliary tract, unspecified |
| DD94 | Functional disorder of the gallbladder |
| DE2Z | Diseases of the digestive system, unspecified |
| EA80.0 | Infantile atopic eczema |
| EA80.1 | Childhood atopic eczema |
| EA80.2 | Adult atopic eczema |
| EA80.Z | Atopic eczema, unspecified |
| EA82 | Nummular dermatitis |
| EA85.20 | Atopic hand eczema |
| EA85.2Z | Hand dermatitis, unspecified |
| EA85.3 | Foot dermatitis |
| EA89 | Generalized eczematous dermatitis of unspecified type |
| EA8Z | Dermatitis or eczema, unspecified |
| EA90.Z | Psoriasis, unspecified |
| GA15.1 | Erosion or ectropion of cervix |
| GA90 | Hyperplasia of prostate |
| GA91.Z | Inflammatory and other diseases of prostate, unspecified |
| MD95 | Heartburn |
| NE11 | Burn of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Take orally with a small amount of water. Swallow the capsules whole; do not chew.
For adults and adolescents over 12 years, the standard dose is one 200 mg capsule three times daily.
Administer capsules 30 minutes before meals for optimal absorption and therapeutic effect.
The typical treatment course lasts from one to three months. Repeat courses are possible after consultation with a physician.
For anthelmintic purposes against tapeworms, follow a specific regimen: take a single dose of 20-30 capsules for adults. Adjust the pediatric dose based on age: 10-12 capsules for children 10-12 years, 15 capsules for children 12-15 years. Administer the dose in divided portions over one hour.
For external use, pierce the capsule and apply the oil directly to affected skin or mucous membranes two to three times per day.
Adhere strictly to the prescribed duration of therapy. Do not exceed the recommended dosage.
Adverse Reactions
When taken orally, mild belching is possible, rarely – diarrhea.
Contraindications
Not established.
Pediatric Use
Use is possible according to the dosing regimen.
Special Precautions
Can be used as monotherapy and as part of combination therapy.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer